Harmony Biosciences Inc. (HRMY)

AI Score

Unlock

32.54

0.12 (0.37%)

At close: Apr 02, 2025, 3:59 PM

32.26

-0.86%

After-hours: Apr 02, 2025, 06:44 PM EDT

Dividends

No dividend history available for Harmony Biosciences Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

HRMY News

2 days ago · Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Connect - accessnewswire.com
3 days ago · Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Stockholders to Inquire about Securities Investigation - accessnewswire.com
4 days ago · Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
1 week ago · Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Stockholders to Learn More About the Investigation - accessnewswire.com
1 week ago · Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference - businesswire.com
1 week ago · Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Investors to Inquire about Securities Investigation - accessnewswire.com
1 week ago · INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc. - HRMY - accessnewswire.com
1 week ago · Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Reach Out - accessnewswire.com
1 week ago · Harmony Biosciences: A Compelling Risk-Reward Opportunity - seekingalpha.com
1 week ago · Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands - businesswire.com